NCT00420641 - MDD POC Study GSK372475 Subjects Depressive Disease | Biotech Hunter

Enrollment

492

Participants

Timeline

Start Date

December 19, 2006

Primary Completion Date

June 1, 2008

Study Completion Date

October 15, 2008

Conditions

Depressive Disorder

Interventions

DRUG

GSK372475

GSK372475 1.0-1.5 mg/day

DRUG

Paroxetine

Paroxetine 20-30 mg/day

OTHER

Placebo

Placebo to Match

Trial Locations (33)

1000

GSK Investigational Site, Sofia

4000

GSK Investigational Site, Plovdiv

10000

GSK Investigational Site, Zagreb

10629

GSK Investigational Site, Berlin

16000

GSK Investigational Site, Angoulême

20127

GSK Investigational Site, Milan

21000

GSK Investigational Site, Split

31000

GSK Investigational Site, Toulouse

31200

GSK Investigational Site, Toulouse

35625

GSK Investigational Site, Hüttenberg

39100

GSK Investigational Site, Dole

56126

GSK Investigational Site, Pisa

75014

GSK Investigational Site, Paris

78990

GSK Investigational Site, Élancourt

90402

GSK Investigational Site, Nuremberg

226003

GSK Investigational Site, Lucknow

560029

GSK Investigational Site, Bangalore

560034

GSK Investigational Site, Bangalore

575018

GSK Investigational Site, Mangalore

7500710

GSK Investigational Site, Providencia / Santiago

7510186

GSK Investigational Site, Santiago

7580208

GSK Investigational Site, Santiago

E1V 3G5

GSK Investigational Site, Miramichi

L7R 4E2

GSK Investigational Site, Burlington

L6B 1A1

GSK Investigational Site, Markham

L5M 4N4

GSK Investigational Site, Mississauga

Unknown

GSK Investigational Site, Los Yoses, San José

GSK Investigational Site, San José

01097

GSK Investigational Site, Dresden

576 104

GSK Investigational Site, Manipal

15-879

GSK Investigational Site, Bialystok

86-200

GSK Investigational Site, Chełmno

64-100

GSK Investigational Site, Leszno